Fieber: Thesen innerhalb der Anthroposophischen Medizin und ihre wissenschaftliche Validität

David Martin
Artikel-ID: DMS-20844-DE
DOI: https://doi.org/10.14271/DMS-20844-DE

Zielsetzung: Ziel war die Durchführung eines Scoping-Reviews, um zu charakterisieren, wie Fieber innerhalb der Anthroposophischen Medizin (AM) interpretiert wird, und die wissenschaftliche Validität dieser Thesen zu diskutieren. Methoden: Für die systematische Literaturrecherche wurden Medline, Embase, CAMbase und Google Scholar herangezogen. Auch Textstellen aus Lehrbüchern der Anthroposophischen Medizin und Artikel aus Fachzeitschriften wurden miteinbezogen. Die Daten wurden zusammengetragen und interpretiert. Ergebnisse: Anthroposophische Ärzte zeigen eine positive Einstellung gegenüber Fieber, unterdrücken es selten durch den Einsatz von Antipyretika und greifen häufig auf komplementäre Hilfsmittel zurück, um Beschwerden zu lindern. In der AM wird Fieber potenziell mit den folgenden positiven Aspekten in Zusammenhang gebracht: Es unterstützt die vollständige Genesung; vermindert die Anfälligkeit für rezidivierende Infektionen und atopische Erkrankungen; bietet eine besondere Chance für Betreuungspersonen, liebevolle Zuwendung zu zeigen und Beziehungen zu pflegen; ermöglicht individuelle Entwicklung und stärkt die Widerstandsfähigkeit und Belastbarkeit; schützt vor Krebs und erhöht die Wirksamkeit von Mistelextrakten. Diese Auffassungen werden in einer Zusammenschau mit der verfügbaren wissenschaftlichen Literatur diskutiert. Schlussfolgerungen: Die AM postuliert, dass Fieber sowohl kurzfristig als auch langfristig verschiedene positive Auswirkungen mit sich bringen kann. Einige Theorien und Therapieansätze gelten mittlerweile als evidenzbasiert (werden allerdings dennoch häufig nicht angewendet), während andere noch durch empirische Studien validiert, falsifiziert oder modifiziert werden müssen.

Fever: Views in anthroposophic medicine and their scientific validity

Objective: To conduct a scoping review to characterize how fever is viewed in Anthroposophic Medicine (AM) and discuss the scientific validity of these views. Methods: Systematic searches were run in Medline, Embase, CAMbase, and Google Scholar. Material from anthroposophic medical textbooks and articles was also used. Data was extracted and interpreted. Results: Anthroposophic physicians hold a beneficial view on fever, rarely suppress fever with antipyretics, and often use complementary means of alleviating discomfort. In AM, fever is considered to have the following potential benefits: promoting more complete recovery; preventing infection recurrences and atopic diseases; providing a unique opportunity for caregivers to provide loving care; facilitating individual development and resilience; protecting against cancer and boosting the anticancer effects of mistletoe products. These views are discussed with regard to the available scientific data. Conclusion: AM postulates that fever can be of short-term and long-term benefit in several ways. Many of these opinions have become evidence-based (though still often not practiced) while others still need empirical studies to be validated, refuted, or modified.

1 Bertille N, Purssell E, Corrard F, Chiappini E, Chalumeau M. Fever phobia 35 years later: did we fail? Acta Paediatrica 2016;105(1):9–10.

2 Bertille N, Fournier-Charrière E, Pons G, Chalumeau M. Managing fever in children: a national survey of parents’ knowledge and practices in France. PLOS ONE 2013;8(12):e83469. [Crossref]

3 Chiappini E, Parretti A, Becherucci P, Pierattelli M, Bonsignori F, Galli L, et al. Parental and medical knowledge and management of fever in Italian pre-school children. BMC Pediatrics 2012;12:97. [Crossref]

4 Purssell E. Treatment of fever and over-the-counter medicines. Archives of Disease in Childhood 2007;92(10):900–901. [Crossref]

5 Verfügbar unter http://www.anthromed.de/en/search/ (26. Juli 2016).

6 Kienle GS, Albonico HU, Baars E, Hamre HJ, Zimmermann P, Kiene H. Anthroposophic medicine: an integrative medical system originating in Europe. Glob Adv Health Med 2013;2(6):20–31. [Crossref]

7 Alm JS, Swartz J, Lilja G, Scheynius A, Pershagen G. Atopy in children of families with an anthroposophic lifestyle. The Lancet 1999;353(9163):1485–1488. [Crossref]

8 Hamre HJ, Glockmann A, Schwarz R, Riley DS, Baars EW, Kiene H, et al. Antibiotic use in children with acute respiratory or ear infections: prospective observational comparison of anthroposophic and conventional treatment under routine primary care conditions. Evidence- Based Complementary and Alternative Medicine 2014; Article ID: 243801. [Crossref]

9 Jeschke E, Lüke C, Ostermann T, Tabali M, Hübner J, Matthes H. Verordnungsverhalten anthroposophisch orientierter Ärzte bei akuten Infektionen der oberen Atemwege. Forschende Komplementärmedizin/Research in Complementary Medicine 2007;14(4):207–215. [Crossref]

10 Verfügbar unter http://www.goetheanum.org/87.html?&L=1 (6. Mai 2016).

11 Steiner R, Wegman I. Fundamentals of therapy. Dornach: Rudolf Steiner Verlag; 1925.

12 Girke M, Hoppe JD, Matthiessen PF, Willich SN. Medizin und Menschenbild. Das Verständnis des Menschen in Schul- und Komplementärmedizin. Köln: Deutscher Ärzte-Verlag; 2006.

13 Husemann A, Schad W. Zum Selbstverständnis der Anthroposophischen Medizin. Der Merkurstab 2010;63(4):591–592.

14 Glöckler M, Girke M, Matthes H. Anthroposophische Medizin und ihr integratives Paradigma. In: Uhlenhoff R (Hg). Anthroposophie in Geschichte und Gegenwart. Berlin: Berliner Wissenschafts-Verlag; 2011.

15 Büssing A, Cysarz D, Edelhäuser F, Bornhöft G, Matthiessen PF, Ostermann T. The oil-dispersion bath in anthroposophic medicine – an integrative review. BMC Complementary and Alternative Medicine 2008;8(1):61. [Crossref]

16 Büssing A, Ostermann T, Majorek M, Matthiessen PF. Eurythmy therapy in clinical studies: a systematic literature review. BMC Complementary and Alternative Medicine 2008;8(1):8. [Crossref]

17 Hamre HJ, Witt CM, Glockmann A, Ziegler R, Willich SN, Kiene H. Eurythmy therapy in chronic disease: a four-year prospective cohort study. BMC Public Health 2007;7(1):61. [Crossref]

18 Kienle GS, Kiene H, Albonico HU. Anthroposophic medicine: effectiveness, utility, costs, safety. Stuttgart: Schattauer Verlag; 2006.

19 Soldner G, Stellmann HM. Individuelle Pädiatrie: Leibliche, seelische und geistige Aspekte in Diagnostik und Beratung – Anthroposophisch-homöopathische Therapie. 4. Aufl. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 2011.

20 Girke M. Innere Medizin. Grundlagen und therapeutische Konzepte der Anthroposophischen Medizin. 2. Aufl. Berlin: Salumed Verlag; 2012.

21 Vagedes J, Soldner G. Das Kinder-Gesundheitsbuch. München: Gräfe und Unzer; 2008.

22 Glöckler M, Goebel W. A Guide to Child Health: A Holistic Approach to Raising Healthy Children. 4. Aufl. Edinburgh: Floris Books; 2013.

23 Kummer KR. 1001 mal Masern – prospektive Untersuchung von 886 und retrospektive von 115 Verläufen in der Praxis. Der Merkurstab 1999;52(6):369–375.

24 von Schoen-Angerer T, Wilkens J, Kienle GS, Kiene H, Vagedes J. High-dose Viscum album extract treatment in the prevention of recurrent bladder cancer: a retrospective case series. Perm J 2015;19(4):76–83.

25 Husemann F. Scharlach und eitrige Angina in zehn Jahren Praxis. Der Merkurstab 1998;51(1):16–24.

26 Soldner G, Stellmann HM. Krankheitsbekämpfung und Gesundheitsentwicklung: Therapiemöglichkeiten der Pneumonie im Kindesalter. Der Merkurstab 2002;55(Sonderheft 1):43–49.

27 Harmsen IA, Ruiter RAC, Paulussen TGW, Mollema L, Kok G, de Melker HE. Factors that influence vaccination decisionmaking by parents who visit an anthroposophical child welfare center: a focus group study. Adv Prev Med 2012;Article ID: 175694.

28 Fintelmann V, Hopferwieser M, Kenyeres B, Görnitz S. Die Masernepidemie in Salzburg, Ostern 2008. Der Merkurstab 2011;64(2):128–142.

29 Busche P. Masern im Erwachsenenalter – eine Kasuistik. Der Merkurstab 2015;68(6):455–458.

30 Albonico HU, Bräker HU, Hüsler J. Febrile infectious childhood diseases in the history of cancer patients and matched controls. Med Hypotheses 1998;51(4):315–320. [Crossref]

31 Zerbo O, Iosif AM, Walker C, Ozonoff S, Hansen RL, Hertz-Picciotto I. Is maternal influenza or fever during pregnancy associated with autism or developmental delays? Results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) Study. J Autism Dev Disord 2013;43(1):25–33. [Crossref]

32 Mouihate A, Harré EM, Martin S, Pittman QJ. Suppression of the febrile response in late gestation: evidence, mechanisms and outcomes. J Neuroendocrinol 2008;20(4):508–514. [Crossref]

33 Rice P, Martin E, He JR, Frank M, DeTolla L, Hester L, et al. Febrile-range hyperthermia augments neutrophil accumulation and enhances lung injury in experimental gram-negative bacterial pneumonia. The Journal of Immunology 2005;174(6):3676–3685. [Crossref]

34 Liu E, Lewis K, Al-Saffar H, Krall CM, Singh A, Kulchitsky VA, et al. Naturally occurring hypothermia is more advantageous than fever in severe forms of lipopolysaccharide – and Escherichia coli-induced systemic inflammation. American Journal of Physiology – Regulatory, Integrative and Comparative Physiology 2012;302(12):R1372–R1383. [Crossref]

35 Hasday JD, Garrison A, Singh IS, Standiford T, Ellis GS, Rao S, et al. Febrile-range hyperthermia augments pulmonary neutrophil recruitment and amplifies pulmonary oxygen toxicity. Am J Pathol 2003;162(6):2005–2017. [Crossref]

36 Hong S, Koh Y, Lee I, Kim MJ, Kim WS, Kim D, et al. Induced hypothermia as a new approach to lung rest for the acutely injured lung. Critical Care Medicine 2005;33(9):2049–2055. [Crossref]

37 Ghandi Y, Chaichi PY, Sharifi M, Bolandnazar N, et al. The Brugada syndrome unmasked by fever in a two-year-old child: case report. Journal of Comprehensive Pediatrics 2016;7(1):e35129. [Crossref]

38 Probst V, Denjoy I, Meregalli PG, Amirault JC, Sacher F, Mansourati J, et al. Clinical aspects and prognosis of Brugada syndrome in children. Circulation 2007;115(15):2042–2048. [Crossref]

39 Schortgen F, Clabault K, Katsahian S, Devaquet J, Mercat A, Deye N, et al. Fever control using external cooling in septic shock: a randomized controlled trial. American Journal of Respiratory and Critical Care Medicine 2012;185(10):1088–1095. [Crossref]

40 Shime N, Hosokawa K, Mac- Laren G. Does cooling really improve outcomes in patients with septic shock? American Journal of Respiratory and Critical Care Medicine 2013;187(11):1274–1275. [Crossref]

41 Mina MJ, Metcalf CJE, de Swart RL, Osterhaus A, Grenfell BT. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science 2015;348(6235):694–699. [Crossref]

42 Harden LM, Kent S, Pittman QJ, Roth J. Fever and sickness behavior: Friend or foe? Brain, Behavior, and Immunity 2015;50:322–333. [Crossref]

43 Williams LE, Bargh JA. Experiencing physical warmth promotes interpersonal warmth. Science 2008;322(5901):606–607. [Crossref]

44 Kang Y, Williams LE, Clark MS, Gray JR, Bargh JA. Physical temperature effects on trust behavior: the role of insula. Social Cognitive and Affective Neuroscience 2011;6(4):507–515. [Crossref]

45 Mackowiak PA. Concepts of fever. Arch Intern Med 1998;158(17):1870–1881. [Crossref]

46 Kluger MJ. Phylogeny of fever. In: Federation Proceedings. 1979. Verfügbar unter http://europepmc.org/abstract/med/759235 (15. Februar 2016). [Crossref]

47 Blatteis CM. Fever: is it beneficial? Yale J Biol Med 1986;59(2):107–116.

48 Bernheim HA, Kluger MJ. Fever: effect of drug-induced antipyresis on survival. Science 1976;193(4249):237–239. [Crossref]

49 Eyers S, Weatherall M, Shirtcliffe P, Perrin K, Beasley R. The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analyis. J R Soc Med 2010;103(10):403–411. [Crossref]

50 Doran TF, De Angelis C, Baumgardner RA, Mellits ED. Acetaminophen: more harm than good for chickenpox? J Pediatr 1989;114(6):1045–1048. [Crossref]

51 Brandts CH, Ndjavé M, Graninger W, Kremsner PG. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet 1997;350(9079):704–709. [Crossref]

52 Schulman CI, Namias N, Doherty J, Manning RJ, Li P, et al. The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study. Surg Infect 2005;6(4):369–375. [Crossref]

53 Mackowiak PA. Direct effects of hyperthermia on pathogenic microorganisms: teleologic implications with regard to fever. Rev Infect Dis 1980;3(3):508–520. [Crossref]

54 Mackowiak PA, Marling C. Hyperthermic enhancement of serum antimicrobial activity: mechanism by which fever might exert a beneficial effect on the outcome of gram-negative sepsis. Infect Immun 1983;39(1):38–42.

55 Appenheimer MM, Chen Q, Girard RA, Wang WC, Evans SS. Impact of fever-range thermal stress on lymphocyte-endothelial adhesion and lymphocyte trafficking. Immunological Investigations 2005;34(3):295–323. [Crossref]

56 Roberts NJ. Temperature and host defense. Microbiol Rev 1979;43(2):241–259.

57 Plaisance KI, Kudaravalli S, Wasserman SS, Levine MM, Mackowiak PA. Effect of antipyretic therapy on the duration of illness in experimental influenza A, Shigella sonnei, and Rickettsia rickettsii infections. Pharmacotherapy 2000;20(12):1417–1422. [Crossref]

58 Bryant RE, Hood AF, Hood CE, Koenig MG. Factors affecting mortality of gram-negative rod bacteremia. Arch Intern Med 1971;127(1):120–128. [Crossref]

59 Ahkee S, Srinath L, Ramirez J. Community-acquired pneumonia in the elderly: association of mortality with lack of fever and leukocytosis. South Med J 1997;90(3):296–298. [Crossref]

60 Sutton LP, Dodge KG. The treatment of chorea by induced fever. The Journal of Pediatrics 1933;3(6):813–826. [Crossref]

61 Sutton LP, Dodge KG. Fever therapy in chorea and in rheumatic carditis with and without chorea. The Journal of Laboratory and Clinical Medicine 1936;21(6):619–628.

62 Baize S, Marianneau P, Loth P, Reynard S, Journeaux A, Chevallier M, et al. Early and strong immune responses are associated with control of viral replication and recovery in Lassa virusinfected cynomolgus monkeys. Journal of virology 2009;83(11):5890–5903. [Crossref]

63 Baudouin SV, Saunders D, Tiangyou W, Elson JL, Poynter J, Pyle A, et al. Mitochondrial DNA and survival after sepsis: a prospective study. Lancet 2005;366(9503):2118–2121. [Crossref]

64 Hanada R, Leibbrandt A, Hanada T, Kitaoka S, Furuyashiki T, Fujihara H, et al. Central control of fever and female body temperature by RANKL/RANK. Nature 2009;462(7272):505–509. [Crossref]

65 Young P, Saxena M, Bellomo R, Freebairn R, Hammond N, van Haren F, et al. Acetaminophen for fever in critically ill patients with suspected infection. New England Journal of Medicine 2015;373(23):2215–2224. [Crossref]

66 Prymula R, Siegrist CA, Chlibek R, Zemlickova H, Vackova M, Smetana J, et al. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two openlabel, randomised controlled trials. Lancet 2009;374(9698):1339–1350. [Crossref]

67 Richardson M, Purssell E. Who’s afraid of fever? Archives of Disease in Childhood 2015;100(9):818–820. [Crossref]

68 Beyerlein A, Wehweck F, Ziegler AG, Pflueger M. Respiratory infections in early life and the development of islet autoimmunity in children at increased type 1 diabetes risk: evidence from the BABYDIET study. JAMA Pediatrics 2013;167(9):800–807. [Crossref]

69 Beasley R, Clayton T, Crane J, von Mutius E, Lai CKW, Montefort S, et al. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6–7 years: analysis from Phase Three of the ISAAC programme. The Lancet 2008;372(9643):1039–1048. [Crossref]

70 Etminan M, Sadatsafavi M, Jafari S, Doyle-Waters M, Aminzadeh K, Fitzgerald JM. Acetaminophen use and the risk of asthma in children and adults: a systematic review and metaanalysis. Chest 2009;136(5):1316–1323. [Crossref]

71 Perzanowski MS, Miller RL, Tang D, Ali D, Garfinkel RS, Chew GL, et al. Prenatal acetaminophen exposure and risk of wheeze at age 5 years in an urban low-income cohort. Thorax 2010;65(2):118–123. [Crossref]

72 Kanabar D, Dale S, Rawat M. A review of ibuprofen and acetaminophen use in febrile children and the occurrence of asthmarelated symptoms. Clin Ther 2007;29(12):2716–2723. [Crossref]

73 Williams LK, Peterson EL, Ownby DR, Johnson CC. The relationship between early fever and allergic sensitization at age 6 to 7 years. J Allergy Clin Immunol 2004;113(2):291–296. [Crossref]

74 Williams LK, Peterson EL, Pladevall M, Tunceli K, Ownby DR, Johnson CC. Timing and intensity of early fevers and the development of allergies and asthma. J Allergy Clin Immunol 2005;116(1):102–108. [Crossref]

75 von Mutius E, Illi S, Hirsch T, Leupold W, Keil U, Weiland S. Frequency of infections and risk of asthma, atopy and airway hyperresponsiveness in children. Eur Respir J 1999;14(1):4–11. [Crossref]

76 Ahn KM, Lee MS, Hong SJ, Lim DH, Ahn YM, Lee HR, et al. Fever, use of antibiotics, and acute gastroenteritis during infancy as risk factors for the development of asthma in Korean school-age children. Journal of Asthma 2005;42(9):745–750. [Crossref]

77 Matricardi PM, Franzinelli F, Franco A, Caprio G, Murru F, Cioffi D, et al. Sibship size, birth order, and atopy in 11,371 Italian young men. Journal of Allergy and Clinical Immunology 1998;101(4):439–444. [Crossref]

78 Curran LK, Newschaffer CJ, Lee LC, Crawford SO, Johnston MV, Zimmerman AW. Behaviors associated with fever in children with autism spectrum disorders. Pediatrics 2007;120(6):e1386–e1392. [Crossref]

79 Mehler MF, Purpura DP. Autism, fever, epigenetics and the locus coeruleus. Brain Research Reviews 2009;59(2):388–392. [Crossref]

80 Mischkowski D, Crocker J, Way BM. From painkiller to empathy killer: acetaminophen (paracetamol) reduces empathy for pain. Social Cognitive and Affective Neuroscience 2016;11(9):1345–1353. [Crossref]

81 Schad W. Goethes Weltkultur. Stuttgart: Verlag Freies Geistesleben; 2007.

82 Jones JDF. Teller of Many Tales: The Lives of Laurens van der Post. New York: Carroll & Graf; 2002.

83 Rohen JW, Landman-Reiner A. Functional morphology: the dynamic wholeness of the human organism. The Journal of Alternative and Complementary Medicine 2008;14(7):855–856. [Crossref]

84 Kenney WL, Munce TA. Invited review: aging and human temperature regulation. Journal of Applied Physiology 2003;95(6):2598–2603. [Crossref]

85 Roghmann MC, Warner J, Mackowiak PA. The relationship between age and fever magnitude. Am J Med Sci 2001;322(2):68–70. [Crossref]

86 Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420(6917):860–867. [Crossref]

87 Grossarth-Maticek R, Frentzel-Beyme R, Kanazir D, Jankovic M, Vetter H. Reported herpes-virus-infection, fever and cancer incidence in a prospective study. Journal of Chronic Diseases 1987;40(10):967–976. [Crossref]

88 Wrotek S, Kamecki K, Kwiatkowski S, Kozak W. Cancer patients report a history of fewer fevers during infections than healthy controls. Journal of Pre-Clinical and Clinical Research 2009;3(1):001–010.

89 Kölmel KF, Pfahlberg A, Mastrangelo G, Niin M, Botev I, Seebacher C, et al. Infections and melanoma risk: results of a multicentre EORTC case-control study. Melanoma Research 1999;9(5):511–519. [Crossref]

90 Krone B, Kölmel KF, Grange J, Mastrangelo G, Henz B, Botev I, et al. Impact of vaccinations and infectious diseases on the risk of melanoma – evaluation of an EORTC case-control study. European Journal of Cancer 2003;39(16):2372–2378. [Crossref]

91 Kienle GS, Kiene H. From reductionism to holism: systemsoriented approaches in cancer research. Global Advances in Health and Medicine 2012;1(5):68–77. [Crossref]

92 Kokolus KM, Capitano ML, Lee CT, Eng JW, Waight JD, Hylander BL, et al. Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature. Proceedings of the National Academy of Sciences 2013;110(50):20176–20181. [Crossref]

93 Ostberg JR, Repasky EA. Emerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function. Cancer Immunol Immunother 2006;55(3):292–298. [Crossref]

94 Hanson DF. Fever, temperature, and the immune response. Ann N Y Acad Sci 1997;813:453–464. [Crossref]

95 Blatteis CM. Endotoxic fever: new concepts of its regulation suggest new approaches to its management. Pharmacology & Therapeutics 2006;111(1):194–223. [Crossref]

96 Hajdu S, Holinka J, Reichmann S, Hirschl AM, Graninger W, Presterl E. Increased temperature enhances the antimicrobial effects of daptomycin, vancomycin, tigecycline, fosfomycin, and cefamandole on staphylococcal biofilms. Antimicrobial Agents and Chemotherapy 2010;54(10):4078–4084. [Crossref]

97 Coley WB. The treatment of sarcoma of the long bones. Ann Surg 1933;97(3):434–460. [Crossref]

98 Kienle GS. Fever in cancer treatment: Coley’s therapy and epidemiologic observations. Glob Adv Health Med 2012;1(1):92–100. [Crossref]

99 Hobohm U. Fever and cancer in perspective. Cancer Immunology, Immunotherapy 2001;50(8):391–396.

100 Kleef R, Jonas WB, Knogler W, Stenzinger W. Fever, cancer incidence and spontaneous remissions. Neuroimmunomodulation 2000;9(2):55–64. [Crossref]

101 Hobohm U. Fever therapy revisited. Br J Cancer 2005;92(3):421–425. [Crossref]

102 O’Regan B, Hirshberg C. Spontaneous Remission: An Annotated Bibliography. Sausalito: Institute of Noetic Sciences; 1995.

103 Kleef R, Hager ED. Fever, Pyrogens and Cancer. In: Baronzio G, Hager ED (Hg). Hyperthermia in Cancer Treatment: A Primer. New York: Springer Verlag; 2006. [Crossref]

104 Abdelrazeq AS. Spontaneous regression of colorectal cancer: a review of cases from 1900 to 2005. International Journal of Colorectal Disease 2007;22(7):727–736. [Crossref]

105 Madeleyn R, Soldner G, Tautz C, von Laue B. Hirntumore bei Kindern: Therapieverläufe (Teil II). Der Merkurstab 2002;55(1):36–47.

106 Hoption Cann SA, van Netten JP, van Netten C, Glover D. Spontaneous regression: a hidden treasure buried in time. Medical Hypotheses 2002;58(2):115–119. [Crossref]

107 Takeda Y, Togashi H, Shinzawa H, Miyano S, Ishii R, Karasawa T, et al. Spontaneous regression of hepatocellular carcinoma and review of literature. Journal of Gastroenterology and Hepatology 2000;15(9):1079–1086. [Crossref]

108 Steiner R. Geisteswissenschaft und Medizin. 7. Aufl. Dornach: Rudolf Steiner Verlag; 1999.

109 Orange M. Mistletoe Therapy for Cancer Patients. Thesis for the Degree of Master of Science in Clinical Oncology. The University of Birmingham, UK; 2011. Verfügbar unter http://www.anthromed.org/UploadedDocuments/0_Dissertation_compressed.pdf (6.12.2016). [Crossref]

110 Chernyshov VP, Heusser P, Omelchenko LI, et al. Immunomodulatory and clinical effects of Viscum album (Iscador M and Iscador P) in children with recurrent respiratory infections as a result of the Chernobyl nuclear accident. American Journal of Therapeutics 2000;7(3):195–204. [Crossref]

111 Melzer J, Iten F, Hostanska K, Saller R. Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases. Forsch Komplementmed 2009;16:217–226. [Crossref]

112 Orange M, Lace A, Fonseca MP, von Laue B, Geider S, Kienle GS. Durable regression of primary cutaneous B-cell lymphoma following fever-inducing mistletoe treatment: two case reports. Glob Adv Health Med 2012;1(1):18–25. [Crossref]

113 Schad F, Axtner J, Buchwald D, Happe A, Popp S, Kröz M, et al. Intratumoral mistletoe (Viscum album L) therapy in patients with unresectable pancreas carcinoma: a retrospective analysis. Integrative Cancer Therapies 2014;13(4):332–340. [Crossref]

114 Mabed M, El-Helw L, Shamaa S. Phase II study of viscum fraxini- 2 in patients with advanced hepatocellular carcinoma. British Journal of Cancer 2004;90(1):65–69. [Crossref]

115 Orange M, Reuter U, Hobohm U. Coley’s lessons remembered: augmenting mistletoe therapy. Integrative Cancer Therapies 2016;1534735416649916. [Crossref]

116 Penter R. Der Injektionszeitpunkt und der Verlauf eines Zyklus der endogenen Hyperthermie bei der Mistelerstbehandlung. Der Merkurstab 2011;64(1):20–39.

117 von Laue B, Frühwirth M. Viscum- Therapie und Tumorfieber – zwei Fallbeispiele mit langfristig gutem Verlauf. In: Scheer R, Bauer R, Becker H, Berg PA, Fintelmann V (Hg). Die Mistel in der Tumortherapie: Grundlagenforschung und Klinik. Essen: KVCVerlag; 2001.

118 Semiglazov V, Stepula V, Dudov A, Schnitker J, Mengs U. Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial. Anticancer Research 2006;26(2B):1519–1529.

119 Kienle GS, Kiene H. Influence of Viscum album L (European mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies. Integrative Cancer Therapies 2010;9(2):142–157. [Crossref]

120 Tröger W, Galun D, Reif M, Schumann A, StankoviĆ N, MiliĆeviĆ M. Quality of life of patients with advanced pancreatic cancer during treatment with mistletoe. Deutsches Ärzteblatt International 2014;111(29–30):493–502.

121 Maldacker J. Preclinical investigations with mistletoe (Viscum album L.) extract Iscador. Arzneimittelforschung 2006;56(6A):497–507.

122 Tröger W, Galun D, Reif M, Schumann A, StankoviĆ N, MiliĆeviĆ M. Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival. European Journal of Cancer 2013;49(18):3788–3797. [Crossref]

123 Longhi A, Reif M, Mariani E, Ferrari S. A randomized study on postrelapse disease-free survival with adjuvant mistletoe versus oral etoposide in osteosarcoma patients. Evidence-Based Complementary and Alternative Medicine 2014;210198. [Crossref]

124 El-Radhi ASM. Why is the evidence not affecting the practice of fever management? Arch Dis Child 2008;93(11):918–920. [Crossref]

125 Sullivan JE, Farrar HC, American Academy of Pediatrics, the Section on Clinical Pharmacology and Therapeutics. Clinical report – Fever and antipyretic use in children. Pediatrics 2011;127(3):580–587. [Crossref]

126 Southey ER, Soares-Weiser K, Kleijnen J. Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever. Current Medical Research and Opinion 2009;25(9):2207–2222. [Crossref]

127 Souyri C, Olivier P, Grolleau S, Lapeyre-Mestre M. Severe necrotizing soft-tissue infections and nonsteroidal anti-inflammatory drugs. Clinical and Experimental Dermatology 2008;33(3):249–255. [Crossref]

128 Ford LM, Waksman J. Necrotizing fasciitis during primary varicella. Pediatrics 2000;105(6):1372–1375. [Crossref]

129 Veenstra RP, Manson WE, van der Werf TS, Fijen J, Tulleken JE, Zijlstra JG, et al. Fulminant necrotizing fasciitis and nonsteroidal anti-inflammatory drugs. Intensive Care Medicine 2001;27(11):1831–1831. [Crossref]

130 Hidalgo-Carballal A, Suárez- Mier MP. Sudden unexpected death in a child with varicella caused by necrotizing fasciitis and streptococcal toxic shock syndrome. The American Journal of Forensic Medicine and Pathology 2006;27(1):93–96. [Crossref]

131 Weng TC, Chen CC, Toh HS, Tang HJ. Ibuprofen worsens Streptococcus pyogenes soft tissue infections in mice. Journal of Microbiology, Immunology and Infection 2011;44(6):418–423. [Crossref]

132 Byington CL, Spencer LY, Johnson TA, Pavia AT, Allen D, Mason EO, et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clinical Infectious Diseases 2002;34(4):434–440. [Crossref]

133 François P, Desrumaux A, Cans C, Pin I, Pavese P, Labarère J. Prevalence and risk factors of suppurative complications in children with pneumonia. Acta Paediatrica 2010;99(6):861–866. [Crossref]

134 Elemraid MA, Thomas MF, Blain AP, Rushton SP, Spencer DA, Gennery AR, et al. Risk factors for the development of pleural empyema in children. Pediatric Pulmonology 2015;50(7):721–726. [Crossref]

135 Le Bourgeois M, Ferroni A, Leruez-Ville M, Varon E, Thumerelle C, Brémont F, et al. Nonsteroidal anti-inflammatory drug without antibiotics for acute viral infection increases the empyema risk in children: a matched case-control study. The Journal of Pediatrics 2016;175:47–53. [Crossref]

136 Voiriot G, Dury S, Parrot A, Mayaud C, Fartoukh M. Nonsteroidal antiinflammatory drugs may affect the presentation and course of communityacquired pneumonia. Chest 2011;139(2):387–394. [Crossref]

137 Mikaeloff Y, Kezouh A, Suissa S. Nonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease. British Journal of Clinical Pharmacology 2008;65(2):203–209. [Crossref]

138 Ludvigsson JF. Epidemiological study of constipation and other gastrointestinal symptoms in 8000 children. Acta Paediatrica 2006;95(5):573–580. [Crossref]

139 Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen: a practitionerbased randomized clinical trial. JAMA 1995;273(12):929–933. [Crossref]

140 Nourjah P, Ahmad SR, Karwoski C, Willy M. Estimates of acetaminophen (paracetamol)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf 2006;15(6):398–405. [Crossref]

141 Kang LW, Kidon MI, Chin CW, Hoon LS, Hwee CY, Chong NK. Severe anaphylactic reaction to ibuprofen in a child with recurrent urticaria. Pediatrics 2007;120(3):e742–e744. [Crossref]

142 Bachmeyer C, Vermeulen C, Habki R, Blay F, Leynadier F. Acetaminophen (paracetamol)-induced anaphylactic shock. Southern Medical Journal 2002;95(7):759–761. [Crossref]

143 Jain SS, Green S, Rose M. Anaphylaxis following intravenous paracetamol: the problem is the solution. Anaesthesia & Intensive Care 2015;43(6):779–781.

144 Graham NM, Burrell CJ, Douglas RM, Debelle P, Davies L. Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers. J Infect Dis 1990;162(6):1277–1282. [Crossref]

145 Husseini RH, Sweet C, Collie MH, Smith H. Elevation of nasal viral levels by suppression of fever in ferrets infected with influenza viruses of differing virulence. J Infect Dis 1982;145(4):520–524. [Crossref]

146 Earn DJ, Andrews PW, Bolker BM. Population-level effects of suppressing fever. Proceedings of the Royal Society B: Biological Sciences 2014;281(1778):20132570. [Crossref]

147 Kramer MS, Naimark LE, Roberts B, McDougall A, Leduc DG. Risks and benefits of paracetamol antipyresis in young children with fever of presumed viral origin. Lancet 1991;337(8741):591–594. [Crossref]

148 El-Radhi AS. Lower degree of fever at the initial febrile convulsion is associated with increased risk of subsequent convulsions. Eur J Paediatr Neurol 1998;2(2):91–96. [Crossref]

149 Strengell T, Uhari M, Tarkka R, Uusimaa J, Alen R, Lautala P, et al. Antipyretic agents for preventing recurrences of febrile seizures: randomized controlled trial. Arch Pediatr Adolesc Med 2009;163(9):799–804. [Crossref]

150 Offringa M, Newton R. Prophylactic drug management for febrile seizures in children (Review). Evidence-Based Child Health: A Cochrane Review Journal 2013;8(4):1376–1485. [Crossref]

151 Verity CM, Greenwood R, Golding J. Long-term intellectual and behavioral outcomes of children with febrile convulsions. New England Journal of Medicine 1998;338(24):1723–1728. [Crossref]

152 Thoresen M. Who should we cool after perinatal asphyxia? In: Seminars in Fetal and Neonatal Medicine. Elsevier; 2015. Verfügbar unter http://www.sciencedirect.com/science/article/pii/S1744165X15000153 (28. Mai 2016). [Crossref]

153 Almeida MC, Steiner AA, Branco LG, Romanovsky AA. Cold-seeking behavior as a thermoregulatory strategy in systemic inflammation. European Journal of Neuroscience 2006;23(12):3359–3367. [Crossref]

154 Launey Y, Nesseler N, Mallédant Y, Seguin P. Clinical review: Fever in septic ICU patients – friend or foe? Crit Care 2011;15(3):222. [Crossref]

155 Schmitt BD. Fever phobia: misconceptions of parents about fevers. Am J Dis Child 1980;134(2):176–181. [Crossref]

156 Crocetti M, Moghbeli N, Serwint J. Fever phobia revisited: have parental misconceptions about fever changed in 20 years? Pediatrics 2001;107(6):1241–1246. [Crossref]

157 IVAA – Facts and Figures on Anthroposophic Medicine in Europe. Verfügbar unter http://www.ivaa.info/?p=72 (6. Mai 2011).

158 Ulbricht M. Antipyretische Wirkung eines körperwarmen Einlaufes. Universität Tübingen; 1991.

159 Gesellschaft Anthroposophischer Ärzte in Deutschland (Hg). Vademecum Anthroposophische Arzneimittel. 3. Aufl. Der Merkurstab Supplement 2013;66.

160 Martin DD. Fieberkrämpfe: Hilft Wärme im Fieberanstieg? Zeitschrift für Komplementärmedizin 2017;9(1):38–41. [Crossref]

Merkurstab-Newsletter

Kostenlos und unverbindlich.
Zur Anmeldung

 

Stellenmarkt Anthroposophische Medizin

KLINIK ARLESHEIM
Ärztliche Leitung Psychiatrie/Psychosomatik (100%)
Weitere Informationen

GEMEINSCHAFTSHOSPIZ CHRISTOPHORUS, BERLIN
Gesundheits-/Kranken- und AltenpflegerInnen
Weitere Informationen

KLINIK ARLESHEIM
Oberärztin/Oberarzt Innere Medizin (100%)
Weitere Informationen

HERINGEN/HELME
Anthroposophischer Allgemeinarzt/-ärztin (50-75%) | 2 Krankenschwestern/-pfleger
Weitere Informationen

KLINIK ARLESHEIM
Fachärztin/Facharzt für Allgemeine Innere Medizin (80-100%)
Weitere Informationen

MUTTER/VATER-UND-KIND-KURHEIM ALPENHOF, RETTENBERG/ALLGÄU
Ärztin/Arzt in Teilzeit (50-75%) oder auf Honorarbasis
Weitere Informationen

PARACELSUS-SPITAL RICHTERSWIL
Oberärztin/Oberarzt Innere Medizin (80-100%)
Weitere Informationen